Stelios Papadopoulos, the chairman of the board of the drugmaker based in Cambridge, Massachusetts, bought more than $3 million worth of shares at market price.
The chair of a Massachusetts drugmaker has bought up a lot of shares at market value.
Boston Business Journal BioFlash editor Don Seiffert joins necn to discuss his story, "A vote of confidence for Biogen as chairman buys $3M shares."
